339 related articles for article (PubMed ID: 10338003)
1. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
2. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
Mantripragada KK; Buckley PG; Benetkiewicz M; De Bustos C; Hirvelä C; Jarbo C; Bruder CE; Wensman H; Mathiesen T; Nyberg G; Papi L; Collins VP; Ichimura K; Evans G; Dumanski JP
Int J Oncol; 2003 Mar; 22(3):615-22. PubMed ID: 12579316
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
[TBL] [Abstract][Full Text] [Related]
4. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.
Buckley PG; Mantripragada KK; Díaz de Ståhl T; Piotrowski A; Hansson CM; Kiss H; Vetrie D; Ernberg IT; Nordenskjöld M; Bolund L; Sainio M; Rouleau GA; Niimura M; Wallace AJ; Evans DG; Grigelionis G; Menzel U; Dumanski JP
Hum Mutat; 2005 Dec; 26(6):540-9. PubMed ID: 16287142
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of germline NF2 gene rearrangements.
Legoix P; Sarkissian HD; Cazes L; Giraud S; Sor F; Rouleau GA; Lenoir G; Thomas G; Zucman-Rossi J
Genomics; 2000 Apr; 65(1):62-6. PubMed ID: 10777666
[TBL] [Abstract][Full Text] [Related]
6. High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH.
Bruder CE; Hirvelä C; Tapia-Paez I; Fransson I; Segraves R; Hamilton G; Zhang XX; Evans DG; Wallace AJ; Baser ME; Zucman-Rossi J; Hergersberg M; Boltshauser E; Papi L; Rouleau GA; Poptodorov G; Jordanova A; Rask-Andersen H; Kluwe L; Mautner V; Sainio M; Hung G; Mathiesen T; Möller C; Pulst SM; Harder H; Heiberg A; Honda M; Niimura M; Sahlén S; Blennow E; Albertson DG; Pinkel D; Dumanski JP
Hum Mol Genet; 2001 Feb; 10(3):271-82. PubMed ID: 11159946
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic variability associated with 14 splice-site mutations in the NF2 gene.
Kluwe L; MacCollin M; Tatagiba M; Thomas S; Hazim W; Haase W; Mautner VF
Am J Med Genet; 1998 May; 77(3):228-33. PubMed ID: 9605590
[TBL] [Abstract][Full Text] [Related]
8. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.
Rubio MP; Correa KM; Ramesh V; MacCollin MM; Jacoby LB; von Deimling A; Gusella JF; Louis DN
Cancer Res; 1994 Jan; 54(1):45-7. PubMed ID: 8261460
[TBL] [Abstract][Full Text] [Related]
10. Ring chromosome 22 and neurofibromatosis type II: proof of two-hit model for the loss of the NF2 gene in the development of meningioma.
Zirn B; Arning L; Bartels I; Shoukier M; Hoffjan S; Neubauer B; Hahn A
Clin Genet; 2012 Jan; 81(1):82-7. PubMed ID: 21175598
[TBL] [Abstract][Full Text] [Related]
11. A non-NF2 case of schwannomas of vestibular and trigeminal nerves with different genetic alterations of NF2 gene: case report.
Kambe A; Kamitani H; Watanabe T; Oka A; Inagaki H; Ishii T; Ueki K
Surg Neurol; 2005 Jan; 63(1):62-4; discussion 64-5. PubMed ID: 15639530
[TBL] [Abstract][Full Text] [Related]
12. Neurofibromatosis type 2: genetic and clinical features.
Evans DG
Ear Nose Throat J; 1999 Feb; 78(2):97-100. PubMed ID: 10089694
[TBL] [Abstract][Full Text] [Related]
13. Large intragenic deletions of the NF2 gene: breakpoints and associated phenotypes.
Abo-Dalo B; Kutsche K; Mautner V; Kluwe L
Genes Chromosomes Cancer; 2010 Feb; 49(2):171-5. PubMed ID: 19924781
[TBL] [Abstract][Full Text] [Related]
14. A point mutation associated with a severe phenotype of neurofibromatosis 2.
MacCollin M; Braverman N; Viskochil D; Ruttledge M; Davis K; Ojemann R; Gusella J; Parry DM
Ann Neurol; 1996 Sep; 40(3):440-5. PubMed ID: 8797533
[TBL] [Abstract][Full Text] [Related]
15. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
16. Further genotype--phenotype correlations in neurofibromatosis 2.
Selvanathan SK; Shenton A; Ferner R; Wallace AJ; Huson SM; Ramsden RT; Evans DG
Clin Genet; 2010 Feb; 77(2):163-70. PubMed ID: 19968670
[TBL] [Abstract][Full Text] [Related]
17. Constitutional translocation t(4;22) (q12;q12.2) associated with neurofibromatosis type 2.
Arai E; Ikeuchi T; Karasawa S; Tamura A; Yamamoto K; Kida M; Ichimura K; Yuasa Y; Tonomura A
Am J Med Genet; 1992 Sep; 44(2):163-7. PubMed ID: 1456285
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic variability in monozygotic twins with neurofibromatosis 2.
Baser ME; Ragge NK; Riccardi VM; Janus T; Gantz B; Pulst SM
Am J Med Genet; 1996 Sep; 64(4):563-7. PubMed ID: 8870923
[TBL] [Abstract][Full Text] [Related]
19. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
20. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
